Michal Tomasz Marzec

Michal Tomasz Marzec

Guest researcher

ORCID: 0000-0001-9698-6019

Publication year:
All
41 - 48 out of 48Page size: 10
Sort by: 1st author
  1. Published

    MCPIP1 is a novel link between diabetogenic conditions and impaired insulin secretory capacity

    Tyka, K., Joerns, A., Dunst, A., Tang, Y., Holgersen Bryde, Tenna, Mehmeti, I., Walentinsson, A., Marselli, L., Cnop, M., Tyrberg, B., Marzec, Michal Tomasz & Gurgul-Convey, E., 2021, In: B B A - Molecular Basis of Disease. 1867, 10, 12 p., 166199.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia

    WAtek, M., Wollny, T., Pasiarski, M., Gozdz, S., Durnas, B., Wolak, P., Bucki, R., Marzec, Michal Tomasz, Chabowska, A. & Zendzian-Piotrowska, M., 2017, In: Lipids in Health and Disease. 16, 1

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Jak3 contributes to the activation of ALK and Stat3 in ALK + anaplastic large cell lymphoma. Response.

    Wasik, M. A. & Marzec, Michal Tomasz, 2006, In: Laboratory Investigation. 86, 4, p. 420-421 2 p.

    Research output: Contribution to journal › Letter › Research

  4. Anaplastic lymphoma kinase (ALK)-induced malignancies: novel mechanisms of cell transformation and potential therapeutic approaches

    Wasik, M. A., Zhang, Q., Marzec, Michal Tomasz, Kasprzycka, M., Wang, H. Y. & Liu, X., 2009, In: Seminars in Oncology. 36, 2 Suppl 1, p. S27-35

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Expression of FOXP3(+) regulatory T-cell phenotype in neoplastic and reactive cells in early mycosis fungoides

    Witkiewicz, A. K., Potoczek, M., Kasprzycka, M., Marzec, Michal Tomasz & Wasik, M., Jan 2008, In: Modern Pathology. 21, p. 103A-103A

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. PU.1 activates transcription of SHP-1 gene in hematopoietic cells.

    Wlodarski, P., Zhang, Q., Liu, X., Kasprzycka, M., Marzec, Michal Tomasz & Wasik, M. A., 2007, In: Journal of Biological Chemistry. 282, 9, p. 6316-6323 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Activation of Mammalian Target of Rapamycin in Transformed B Lymphocytes Is Nutrient Dependent but Independent of Akt, Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase, Insulin Growth Factor-I, and Serum.

    Wlodarski, P., Kasprzycka, M., Liu, X., Marzec, Michal Tomasz, Robertson, E. S., Slupianek, A. & Wasik, M. A., 2005, In: Cancer Research. 65, 17, p. 7800-7808 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes.

    Zhang, Q., Wang, H. Y., Marzec, Michal Tomasz, Raghunath, P. N., Nagasawa, T. & Wasik, M. A., 2005, In: Proceedings of the National Academy of Sciences of the United States of America. 102, 19, p. 6948-6953 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 Next

ID: 129941679